Personalized antiplatelet therapy using platelet function testing can decrease ischemic events in stable CAD.
A meta-analysis did not demonstrate a benefit of beta-blockers in reducing major adverse cardiovascular events in a population of patients with stable coronary artery disease without previous history of myocardial infarction or left ventricular dysfunction.
Significantly lower rates of vein graft occlusion seen at three and 12 months for no-touch versus conventional vein harvesting.
The prevalence of obesity and overweight is high among patients with coronary heart disease (CHD), and many patients do not lose weight after discharge from CHD-related hospitalization.
In this study, the researchers examined an association between atherosclerotic cardiovascular disease and risk for cancer in young adults.
The researchers’ goals included quantifying and examining unplanned readmissions within 30 days of CABG surgery, including their causes and associated factors.
The researchers studied the Veterans Affairs data to evaluate the association of pre-operative hemoglobin A1c and long-term outcome after isolated coronary artery bypass grafting.
Investigators assessed outcomes following discontinuation of statins while maintaining the use of other drugs in older patients receiving polypharmacy.
The researchers studied the effect of aspirin and statin treatment on cardiovascular and bleeding incidence in patients with diabetes in the absence of obstructive CAD.
The study objective was to compare the change in the rate of memory decline after PCI vs CABG.